Net profit of Sudeep Pharma rose 65.31% to Rs 47.46 crore in the quarter ended December 2025 as against Rs 28.71 crore during the previous quarter ended December 2024. Sales rose 49.16% to Rs 172.34 crore in the quarter ended December 2025 as against Rs 115.54 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales172.34115.54 49 OPM %34.8034.01 - PBDT65.6440.32 63 PBT61.7837.66 64 NP47.4628.71 65 Powered by Capital Market - Live News

Sudeep Pharma will hold a meeting of the Board of Directors of the Company on 6 February 2026.Powered by Capital Market - Live News

Sudeep Pharma will hold a meeting of the Board of Directors of the Company on 19 December 2025.Powered by Capital Market - Live News

The equity shares of Sudeep Pharma (Scrip Code: 544619) are listed effective 28 November 2025 and admitted to dealings on the Exchange in the list of ``B`` Group Securities. At 09:31 IST, the pre-open indicative price of the stock was at a premium of 13.83% to the offer price of Rs 593. Powered by Capital Market - Live News